Pitisuttithum P. Chapter 3 HIV Vaccine Research in Thailand National Perspective: Overview of HIV Vaccine Research in Thailand. In : Pitisuttithum P, Francis DP, Esparza J, Thongcharoen P, eds. HIV Vaccine Research and Development in Thailand. Bangkok:Amarin Printing and Publishing Public Company; 2006:83-92.

Pitisuttithum P, Migasena S, Singhasivanon P. Chapter 4 Phase I/II HIV Vaccine Trials in Thailand: The Vaccine Trial Center, Faculty of Tropical Medecine, Mahidol University. In : Pitisuttithum P, Francis DP, Esparza J, Thongcharoen P, eds. HIV Vaccine Research and Development in Thailand. Bangkok: Amarin Printing and Publishing Public Company; 2006: 131-150.

Pitisuttithum P, Vanichseni S, Kitayaporn D, Choopanya K. Chapter 7 Conducting Phase III Trials of Candidate HIV Vaccines:Phase III Efficacy Trial of Bivalent B/E rgp 120 HIV Vaccine (AIDSVAX^®  B/E) in Bangkok. In: Pitisutthithum P, Francis DP, Esparza J, Thongcaroen P, eds, HIV Vaccine Research and Development in Thailand. Bangkok: Amarin Printing and Publishing Public Company; 2006:275-290.

Pitisuttithum P, Francis DP, Esaparza J, Thongcharoen P. Chapter 8 Epilogue: Lessons Learnt. In : Pitisuttithum P, Francis DP, Esparza J, Thongcharoen P, eds. HIV Vaccine Research and Development in Thailand. Bangkok: Amarin Printing and Publishing Public Company; 2006:337-342.

Pitisuttithum P, Gilbert P, Gurwith M, Heyward W, Martin M, van Griensven F, Hu D, Tappero JW, Choopanya K. Randomized, Double-Blind, Placebo-Controlled Efficacy Trial of a Bivalent Recombinant Glycoprotein 120 HIV-1 Vaccine among Injection Drug Users in Bangkok, Thailand. J Infect Dis. 2006 Dec 15; 194(12):1661-1671.

Tansuphaswadikul S, Maek-a-nantawat W, Phonrat B, Boonpok L, Getahun A, Pitisuttithum P.Comparison of One Week with Two Week Regimens of Amphotericine B Both followed by Fluconazole in the Treatment of Cryptococcal Meningitis among AIDS Patients. J Med Assoc Thai 2006; 89(10):1677-1685

Getahun A, Tansuphasawadikul S, Desakorn V, Dhitavat J, Pitisuttithum P. Efficacy and safety of generic fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-vir) in advanced HIV infection. J Med Assoc Thai. 2006 Sep;89(9):1472-8.

Raad II, Graybill JR, Bustamante AB, Cornely OA, Gaona-Flores V, Afif C, Graham DR, Greenberg RN, Hadley S, Langston A, Negroni R, Perfect JR, Pitisuttithum P, Restrepo A, Schiller G, Pedicone L, Ullmann AJ. Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections. Clin Infect Dis. 2006; 42(12):1726-34

Gupta SB, Mast CT, Wolfe ND, Novitsky V, Dubey SA, Kallas EG, Schechter M, Mbewe B, Vardas E, Pitisuttithum P, Burke D, Freed D, Mogg R, Coplan PM Condra JH, Long RS, Anderson K,  Casimiro DR, Shiver JW, Straus WL. Cross-clade reactivity of HIV-1-specific T-cell responses in HIV-1-infected individuals from Botswana and Cameroon. J Acquir Immune Defic Syndr. 2006; 42(2):135-9

Home